[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.150.215. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
May 2, 2007

Mandatory HPV VaccinationPublic Health vs Private Wealth

Author Affiliations
 

Author Affiliations: Georgetown Law Center, Washington, DC (Dr Gostin). Dr DeAngelis is Editor in Chief, JAMA.

JAMA. 2007;297(17):1921-1923. doi:10.1001/jama.297.17.1921

By any measure, genital human papillomavirus (HPV) infection and HPV-associated cervical cancer are significant national and global public health concerns. An estimated 11 000 newly diagnosed cases of cervical cancer occur annually in the United States, resulting in 3700 deaths.1 Globally, an estimated 493 000 new cervical cancer cases occur each year, with 274 000 deaths; more than 80% of cervical cancer deaths worldwide occur in developing countries.2

First Page Preview View Large
First page PDF preview
First page PDF preview
×